Breaking News

Close

Novo Nordisk A/S (NVON)

	Symbol	Exchange	Currency
	NVO	NYSE	USD	Real-time
	NOVOBc	BATS Europe	DKK	Delayed
	0QIU	London	DKK	Real-time
	NVON	Mexico	MXN	Delayed
	NOVG	Dusseldorf	EUR	Delayed
	NOVG	Xetra	EUR	Delayed
	NOVG	Frankfurt	EUR	Delayed
	NOVOb	Copenhagen	DKK	Real-time
	NNO2	Vienna	EUR	Real-time

Add to/Remove from Watchlist Add to Watchlist

2,244.590 +97.590 +4.55%

15:59:58 - Closed. Currency in MXN ( Disclaimer )

Type: Equity

Market: Mexico

ISIN: US6701002056

Volume: 1,083
Bid/Ask: 2,161.000 / 2,244.590
Day's Range: 2,162.000 - 2,244.590

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

NYSE:NVON Financials

A brief overview of the NYSE:NVO financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Novo Nordisk over time.

Novo Nordisk A/S reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was DKK 58,731 million compared to DKK 45,566 million a year ago. Net income was DKK 22,478 million compared to DKK 14,405 million a year ago.For the nine months, sales was DKK 166,398 million compared to DKK 128,862 million a year ago. Net income was DKK 61,720 million compared to DKK 41,933 million a year ago.

Annual Quarterly

InvestingPro

Advanced Financial Summary

TTM = Trailing Twelve Months

MRQ = Most Recent Quarter

NVON Income Statement

Gross margin TTM 84.6%

Operating margin TTM 44.77%

Net Profit margin TTM 36.03%

Return on Investment TTM 68.52%

Total Revenue Net Income

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue	65863	58731	54300	53367
Gross Profit	55849	49018	46444	45185
Operating Income	28180	26913	23888	25007
Net Income	21963	22478	19428	19814

NVON Balance Sheet

Quick Ratio MRQ 0.56

Current Ratio MRQ 0.82

LT Debt to Equity MRQ 14.99%

Total Debt to Equity MRQ 25.34%

Total Assets Total Liabilities

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets	314486	300101	280753	250025
Total Liabilities	207925	207110	190280	170151
Total Equity	106561	92991	90473	79874

NVON Cash Flow Statement

Cash Flow/Share TTM 24.43

Revenue/Share TTM 52.1

Operating Cash Flow 5.63%

Cash Net Change in Cash

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Period Length:	0 Months	0 Months	0 Months	0 Months
Cash From Operating Activities	9551	40966	28577	29814
Cash From Investing Activities	-14717	-13243	-9285	-6647
Cash From Financing Activities	-10116	-19832	-12589	-20621
Net Change in Cash	-15491	8309	6638	2283

* In Millions of DKK (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

NVO Comments

Write your thoughts about Novo Nordisk A/S

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Grumpy Cat Apr 18, 2024 9:38AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

this company was doing so well, what happened.

0 0

Jackson Nahm 4 hours ago

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Profit taking imo, it’ll go higher

0 0

Keith Dunkelbarger Apr 17, 2024 6:27PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

A1C down from 9.4 to 6.2 and weight down from 254 to 238 with Ozempic. Lot of flatulence and air freshener.

0 0

yeongjin white Mar 14, 2024 11:38PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

300 by 2024

6 0

roy reyes Feb 05, 2024 8:07PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

gonna dominate the obesity space with Catalent mreger

2 0

Karsten Vester Feb 01, 2024 4:37AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

450 by 2030.. Serving 1 mill custumors now and there are 800 mill. U do the math..

7 0

D Petersen Jan 29, 2024 8:45PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

NVO should advance nicely Wednesday on good earnings and a bright 2024 outlook.

2 1

Karsten Vester Nov 28, 2023 9:52AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Eli is very keen on disrupting NN but they dont even have cardio vascular studies or a candidate for next generation but NN dos. They are way behind so dont be disrupted by their lobby activities ….

4 3

In the Money Oct 21, 2023 7:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

140+ eoy

4 1

Paul Chan Oct 21, 2023 7:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Not with the recent deaths from Ozempic.

0 3

Karsten Vester Oct 21, 2023 7:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Come with dome documentstion dude. Far out to say

0 0

dar dar Oct 13, 2023 12:22PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

like all things, eventually we will know the outcome

0 2

Karsten Vester Oct 03, 2023 11:54AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Now all small investors seems to fanzy ophra Winfrey to dictate the benefits and dowfalls in pharma industry. What a world with celebraties and you tupers now rules the world. S… t.. f… up woman - you dont know what you are talking about and go back to girlish problems and your billions..

1 1

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="224458244">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="224458244" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="224458244" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="224458244">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="224458244">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="224458244" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="224458244" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="224458244">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,508.7	+5.0	+0.01%
	US 500	5,078.2	+7.7	+0.15%
	Dow Jones	38,503.69	+263.71	+0.69%
	S&P 500	5,070.55	+59.95	+1.20%
	Nasdaq	15,696.64	+245.34	+1.59%
	S&P 500 VIX	15.69	-1.25	-7.38%
	Dollar Index	105.530	-0.383	-0.36%

	Crude Oil WTI	83.46	+0.07	+0.08%
	Brent Oil	88.45	+0.01	+0.01%
	Natural Gas	2.132	+0.001	+0.05%
	Gold	2,335.90	+0.10	+0.00%
	Silver	27.308	-0.037	-0.14%
	Copper	4.4177	-0.0063	-0.14%
	US Soybeans	1,166.75	+5.75	+0.50%

	U.S. 10Y	4.603	+0.004	+0.09%
	U.S. 30Y	4.730	+0.007	+0.15%
	U.S. 5Y	4.633	0.011	0.23%
	U.S. 3M	5.413	+0.018	+0.33%
	US 10Y T-Note	108.05	-0.03	-0.03%
	Euro Bund	130.96	-0.24	-0.18%
	10-2 Yield Spread	-36.50	+0.22	+-0.60%

	Apple	166.82	+0.98	+0.59%
	Alphabet A	158.27	+1.99	+1.27%
	Tesla	144.61	+2.56	+1.80%
	Amazon.com	179.51	+2.29	+1.29%
	Netflix	577.51	+22.92	+4.13%
	Meta Platforms	495.77	+14.05	+2.92%
	Bank of America	38.37	+0.64	+1.70%

Recent Quotes

	Name	Price	Chg.	Chg. %
	NVON	2,244.590	+97.590	+4.55%

	Name	Last	Chg. %	Vol.
	TSLA	144.61	+1.80%	95.40M
	AMD	152.24	+2.42%	44.37M
	AAPL	166.82	+0.59%	43.55M
	NVDA	824.18	+3.65%	42.50M
	META	495.77	+2.92%	14.38M
	SMCI	761.86	+6.25%	8.19M
	BRKa	615,108	-0.35%	13.05K

	Name	Last	Chg. %	Vol.
	GL	75.84	+14.23%	9.30M
	GE	162.66	+8.30%	18.43M
	MDB	366.31	+7.69%	1.70M
	DHR	253.11	+7.21%	6.52M
	SMCI	761.86	+6.25%	8.19M
	KMB	136.00	+5.48%	5.67M
	NCLH	19.55	+5.47%	10.18M

	Name	Last	Chg. %	Vol.
	LKQ	41.65	-14.88%	9.64M
	MSCI	446.09	-13.41%	3.64M
	NUE	174.54	-8.92%	4.76M
	IVZ	14.58	-6.42%	10.98M
	WRB	79.08	-5.21%	3.95M
	PKG	170.88	-4.69%	1.44M
	FDS	420.01	-4.20%	354.14K